Recent work shows that STAT3 is an Sp-regulated gene in pancreatic cancer cells that can be targeted by BITC and other ROS inducers, establishing a potential therapeutic strategy for targeting STAT3 [285]. The gene discussed is STAT3; the disease is familial pancreatic carcinoma.